Achyut Healthcare Ltd is a pharmaceutical trading company that was established in 1996 and is based in Ahmedabad, Gujarat. The company trades in pharmaceutical products, medical devices, and APIs. It manufactures tablets, capsules, oral liquids, and injectables, and also customizes products for domestic and international markets. looking for 59 price in upcoming...
AMEX:XLV has formed a five-week equilibrium. The price contraction is already quite tight, indicating that this equilibrium could break very soon. The context is highly bullish: the XLV price is on a weekly uptrend, and the broader market is also showing strong performance. The odds are in favor of an upside breakout. On the chart, there is an example of a...
Last time we looked into United Health (UNH) we gave a strong buy signal (October 03 2023, see chart below), which turned out to be very successful: After getting rejected on Resistance 3, the stock started to decline structurally within a Channel Down. It is a pattern similar to the Channel Down of November 2022 - March 2023, which was again formed after UNH...
Positive news on phase 3 trials. Possible US food & drug admin application next year 2025 8.5 times the usual 20 daily volume average. Red to green reversal. This all points towards likely higher prices. If their application next year gets approved expect a monster move. Investors will likely try to front run this.
Eli Lilly (LLY) has basically turned sideways since the February 16 High. The dominant pattern is a Channel Up since the March 07 2023 Low and can be divided into 3 Bullish Waves that delivered rallies between +45% and +52%. Every time the price hit the 1D MA50 (blue trend-line), it was a buy opportunity. The 1D RSI in particular has a Buy Zone, which coincided...
Dr Lal Pathlabs one of the largest players of healthcare industry in India has a beaten down stock price currently. It is approximately 53.29% down from it's lifetime high. There is not a single reason for such stock price. The company is posting good results and is consistently showing profits. But the stock is highly undervalued. It is a good time to buy it as...
Buy $4 dollar stock. Sell $7 or $12. place Stop loss 0.50c below the dashed-line for your protection. Live-Laugh-Love. Let's make 2024 great.
SPDR Select Sector Fund – Healthcare Index AMEX:XLV The chart speaks for itself, we have our breakout levels and our break down levels. We enter on a breakout and set a stop 5% under that support and we exit and or short if we fall under the two underside support levels. Below I outline some reasons why the healthcare sector is worth paying attention too....
Notes on how I personally use my charts/NFA: Each level L1-L3 and TP1-TP3 (Or S1-S3) has a deployment percentage. The idea is to flag these levels so I can buy 11% at L1 , 28% at L2 and if L3 deploy 61% of assigned dry powder. The same in reverse goes for TP. TP1: 61%, TP2:28% and TP3:11%. If chart pivots between TP's, in-between or in Between Sell levels these...
Heavy volume recently and bullish weekly candle. It could retest 20-22. As long as it stays above 20, I am expecting this could hit 60 in couple of years.
Netcare has been in its downtrend since May 2023... It shortly dropped from R16.00 down to R13.68. And then, the price has been meandering in a downtrend below the 200MA since... As long as it stays in the Vuvuzela Formation, it will continue to go down. We need a strong breakout and for the price to close above the resistance of the pattern, before we put...
Shares of PaxMedica (NASDAQ:PXMD) shot up 110% in early trading after the biotech company said that it now expects to file its New Drug Application for PAX-101 in the second half of 2024. The biotech company said it received constructive feedback at a recent type-B meeting with the FDA that will help it complete the application. It added that most of the work...
Eli Lilly and Company (LLY) has long been one of our best investments a real gem that even withstood and was practically unaffected by the 2022 inflation crisis. For long we have been using the Fibonacci Channel to display LLY's parabolic nature having broken above the 2.0 Fibonacci extension last May. This time the price reversed much quicker than technically...
HealthCare looks to have just closed the week with a failed breakout. Getting a weekly close below the impulse breakout green canceled is never a good sign. Off of Bearish consolidation some Health care stocks may be a good short play. Using the up-sloping trend line & weekly 200 MA as support. Using the Weekly 100 MA as resistance . Recapturing the Weekly...
This is usually a market leader! When market leaders trigger bearish patterns, you need to be cautious. Not an all out short but with bearish consolidation under the neckline it's worth taking a stab. As long as rejection occurs at the neckline this could see like downside.
nse:syngene international current price 940 weekly breakout flag breakout great fundamentals keep on buy for great profits consolidation breakout 100% buy rating 1st target - 900
This is my personal view that Gland Pharma Ltd ha very potential uptrend for coming future. I tried to figure it out with the Fib Retracement with Anchored volume profile. As I have noticed it retraced exactly from -1.618 (905.85). Target 1.618, which is 3190.45 Let me know if you have different views.. Thanks for viewing.
On the weekly timeframe XLV continues to coil. On the daily timeframe we may have seen a double top after the rejection at the bottom of the gap (136.50 area). FWIW these options can move, but they are low volume. On high momentum days trading the same week can be effective. Personally, I prefer to bid for calls on red days and puts on green days with swing...